1-13 of 13
Jean Louis Selam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: A randomized open parallel multicenter study

Geremia B. Bolli, MD, David Kerr, MD, Reena Thomas, MD, Elisabetta Torlone, MD, Agnès Sola-Gazagnes, MD, Ester Vitacolonna, MD, Jean Louis Selam, MD, Philip D. Home, DM, DPHIL
Journal: Diabetes Care
Diabetes Care 2009;32(7):1170–1176
https://doi.org/10.2337/dc08-1874
Published: 23 April 2009
View article titled, Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: <subtitle>A randomized open parallel multicenter study</subtitle>
Open the PDF for Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: <subtitle>A randomized open parallel multicenter study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression : Response to Hirshberg et al.

M. Arthur Charles, MD, PHD,, Jean-Louis Selam, MD
Journal: Diabetes Care
Diabetes Care 2004;27(5):1249–1250
https://doi.org/10.2337/diacare.27.5.1249-a
Published: 01 May 2004
View article titled, Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression : <subtitle>Response to Hirshberg et al. </subtitle>
Open the PDF for Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression : <subtitle>Response to Hirshberg et al. </subtitle> in another window
Journal Articles

Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart

Philippe Vague, MD, PHD, Jean-Louis Selam, MD, Svein Skeie, MD, Ivo De Leeuw, Jan W.F. Elte, MD, PHD, Hanne Haahr, PHD, Allan Kristensen, MSC, Eberhard Draeger, PHD
Journal: Diabetes Care
Diabetes Care 2003;26(3):590–596
https://doi.org/10.2337/diacare.26.3.590
Published: 01 March 2003
View article titled, Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart
Open the PDF for Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart in another window
Journal Articles

Lispro Insulin Is Suitable for External Pumps but Not for Implantable Pumps

Sylvie Demirdjian, PHD, Christophe Bardin, PHD, Sandrine Savin, PHD, Phédon Zirinis, PHD, François Chast, PHD, Gerard Slama, MD, Jean-Louis Sélam, MD
Journal: Diabetes Care
Diabetes Care 1998;21(5):867–868
https://doi.org/10.2337/diacare.21.5.867
Published: 01 May 1998
View article titled, Lispro Insulin Is Suitable for External Pumps but Not for Implantable Pumps
Open the PDF for Lispro Insulin Is Suitable for External Pumps but Not for Implantable Pumps in another window
Journal Articles

Decreased Severe Hypoglycemia Frequency During Intraperitoneal Insulin Infusion Using Programmable Implantame Pumps

Nathalie Jeandidier, MD, Jean-Louis Selam, MD, Eric Renard, MD, Bruno Guerci, MD, Veronique Lassman-Vague, MD, Laure Rocher, MD, Hélène Hanaire-Broutin, MD, The Evadiac Study Group
Journal: Diabetes Care
Diabetes Care 1996;19(7):780
https://doi.org/10.2337/diacare.19.7.780
Published: 01 July 1996
View article titled, Decreased Severe Hypoglycemia Frequency During Intraperitoneal Insulin Infusion Using Programmable Implantame Pumps
Open the PDF for Decreased Severe Hypoglycemia Frequency During Intraperitoneal Insulin Infusion Using Programmable Implantame Pumps in another window
Journal Articles

Diagnostic Procedures for Catheter Malfunction in Programmable Impiantante Intraperitoneal Insulin Infusion Devices

Craig L Olsen, MD, Dee S Turner, RN, MSN, ANP, Mohamad Iravani, BS, Kenneth Waxman, MD, Jean-Louis Selam, MD, M Arthur Charles, MD, PHD
Journal: Diabetes Care
Diabetes Care 1995;18(1):70–76
https://doi.org/10.2337/diacare.18.1.70
Published: 01 January 1995
View article titled, Diagnostic Procedures for Catheter Malfunction in Programmable Impiantante Intraperitoneal Insulin Infusion Devices
Open the PDF for Diagnostic Procedures for Catheter Malfunction in Programmable Impiantante Intraperitoneal Insulin Infusion Devices in another window
Journal Articles

A Cost-Benefit Comparison of Intensive Diabetes Management With Implantable Pumps Versus Multiple Subcutaneous Injections in Patients With Type I Diabetes

Marie-Joelle Haardt, MD, Jean-Louis Selam, MD, Gerard Slama, MD, Jean-Pierre Bethoux, MD, Catherine Dorange, MD, Brigitte Mace, RN, Marie-Lou Ramaniche, RN, Françoise Bruzzo, BS
Journal: Diabetes Care
Diabetes Care 1994;17(8):847–851
https://doi.org/10.2337/diacare.17.8.847
Published: 01 August 1994
View article titled, A Cost-Benefit Comparison of Intensive Diabetes Management With Implantable Pumps Versus Multiple Subcutaneous Injections in Patients With Type I Diabetes
Open the PDF for A Cost-Benefit Comparison of Intensive Diabetes Management With Implantable Pumps Versus Multiple Subcutaneous Injections in Patients With Type I Diabetes in another window
Journal Articles

Insulin Antibody Responses After Long-Term Intraperitoneal Insulin Administration via Impiantatile Programmable Insulin Delivery Systems

Craig L Olsen, MD, Eve Chan, MS, Dee S Turner, MSN, Mohamed Iravani, BS, Maria Nagy, PHD, Jean-Louis Selam, MD, Nathan D Wong, PHD, Ken Waxman, MD, M Arthur Charles, MD, PHD
Journal: Diabetes Care
Diabetes Care 1994;17(3):169–176
https://doi.org/10.2337/diacare.17.3.169
Published: 01 March 1994
View article titled, Insulin Antibody Responses After Long-Term Intraperitoneal Insulin Administration via Impiantatile Programmable Insulin Delivery Systems
Open the PDF for Insulin Antibody Responses After Long-Term Intraperitoneal Insulin Administration via Impiantatile Programmable Insulin Delivery Systems in another window
Journal Articles

Clinical Trial of Programmable Implantable Insulin Pump For Type I Diabetes

Jean-Louis Selam, MD, Piero Micossi, MD, Frederick L Dunn, MD, David M Nathan, MD, Implantable Insulin Pump Trial Study Group
Journal: Diabetes Care
Diabetes Care 1992;15(7):877–885
https://doi.org/10.2337/diacare.15.7.877
Published: 01 July 1992
View article titled, Clinical Trial of Programmable Implantable Insulin Pump For Type I Diabetes
Open the PDF for Clinical Trial of Programmable Implantable Insulin Pump For Type I Diabetes in another window
Journal Articles

Randomized Comparison of Metabolic Control Achieved by Intraperitoneal Insulin Infusion With Implantable Pumps Versus Intensive Subcutaneous Insulin Therapy in Type I Diabetic Patients

Jean-Louis Selam, MD, Denis Raccah, MD, Nathalie Jean-Didier, MD, Jim L Lozano, BS, Ken Waxman, MD, M Arthur Charles, MD, PHD
Journal: Diabetes Care
Diabetes Care 1992;15(1):53–58
https://doi.org/10.2337/diacare.15.1.53
Published: 01 January 1992
View article titled, Randomized Comparison of Metabolic Control Achieved by Intraperitoneal Insulin Infusion With Implantable Pumps Versus Intensive Subcutaneous Insulin Therapy in Type I Diabetic Patients
Open the PDF for Randomized Comparison of Metabolic Control Achieved by Intraperitoneal Insulin Infusion With Implantable Pumps Versus Intensive Subcutaneous Insulin Therapy in Type I Diabetic Patients in another window
Journal Articles

Devices for Insulin Administration

Jean-Louis Selam, MD, M Arthur Charles, MD, PhD
Journal: Diabetes Care
Diabetes Care 1990;13(9):955–979
https://doi.org/10.2337/diacare.13.9.955
Published: 01 September 1990
View article titled, Devices for Insulin Administration
Open the PDF for Devices for Insulin Administration in another window
Journal Articles

Heparin Addition to Insulin in Implantable Pumps to Prevent Catheter Obstruction

Jean-Louis Selam, MD, Peter Lord, William P Van Antwerp, Rae E Drazin, PhD, Judith Kandel, PhD, MPH, M Arthur Charles, MD, PhD
Journal: Diabetes Care
Diabetes Care 1989;12(1):38–39
https://doi.org/10.2337/diacare.12.1.38
Published: 01 January 1989
View article titled, Heparin Addition to Insulin in Implantable Pumps to Prevent Catheter Obstruction
Open the PDF for Heparin Addition to Insulin in Implantable Pumps to Prevent Catheter Obstruction in another window
Journal Articles

Stable Insulin for Implantable Delivery Systems: In Vitro Studies With Different Containers and Solvents

Jean-Louis Selam, MD, Phedon Zirinis, PhD, Marc Mellet, PhD, Jacques Mirouze, MD
Journal: Diabetes Care
Diabetes Care 1987;10(3):343–347
https://doi.org/10.2337/diacare.10.3.343
Published: 01 May 1987
View article titled, Stable Insulin for Implantable Delivery Systems: In Vitro Studies With Different Containers and Solvents
Open the PDF for Stable Insulin for Implantable Delivery Systems: In Vitro Studies With Different Containers and Solvents in another window